Integer Holdings Corporation (ITGR)

121,24 -0,41 (-0,34%) Börsenschluss: 04:00PM EDT

Integer Holdings Corporation

5830 Granite Parkway
Suite 1150
Plano, TX 75024
United States
214 618 5243
https://www.integer.net

Sektor(en): Healthcare
Branche: Medical Devices
Vollzeitmitarbeiter: 10.500

Leitende Angestellte

Name	Titel	Zahlen	Ausgeübt	Geburtsjahr
Mr. Joseph W. Dziedzic	President, CEO & Director	3,24M	713,51k	1968
Mr. Diron Smith	Executive VP & CFO	651,22k	N/A	1974
Mr. McAlister C. Marshall II	Senior VP, General Counsel, Chief Ethics & Compliance Officer and Corporate Secretary	854,89k	N/A	1970
Mr. Kirk K. Thor	Executive VP & Chief Human Resources Officer	791,64k	N/A	1964
Mr. Payman Khales	President of Cardio & Vascular	1,14M	N/A	1970
Mr. John Harris	Executive Vice President of Global Operations & Manufacturing Strategy	521,18k	42,65k	1960
Mr. Tom P. Thomas	VP, Corporate Controller & Principal Accounting Officer	N/A	N/A	1971
Mr. Andrew Senn	Senior Vice President of Strategy, Business Development & Investor Relations	N/A	N/A	1982
Ms. Margaret Carthy	Executive VP of Global Quality & Regulatory Affairs	N/A	N/A	1964
Mr. Jim Stephens	President of Cardiac Rhythm Management & Neuromodulation	N/A	N/A	1974

Die Beträge haben den Stand 31. Dezember 2023 und Kompensationswerte gelten für das letzte Geschäftsjahr bis zu diesem Datum. Der Lohn umfasst Gehalt, Boni usw. „Ausgeübt“ entspricht dem Wert von Optionen, die im Lauf des Geschäftsjahrs ausgeübt werden. Währung in USD.

Beschreibung

Integer Holdings Corporation operates as a medical device outsource manufacturer in the United States, Puerto Rico, Costa Rica, and internationally. It operates through two segments, Medical and Non-Medical. The company offers products for interventional cardiology, structural heart, heart failure, peripheral vascular, neurovascular, interventional oncology, electrophysiology, vascular access, infusion therapy, hemodialysis, non-vascular, urology, and gastroenterology procedures. It also provides cardiac rhythm management products, including implantable pacemakers, implantable cardioverter defibrillators, insertable cardiac monitors, implantable cardiac pacing and defibrillation leads, and heart failure therapies; neuromodulation products, such as implantable spinal cord stimulators; and non-rechargeable batteries, feedthroughs, device enclosures, machined components, and lead components and sub-assemblies. In addition, the company offers rechargeable batteries and chargers; and arthroscopic, laparoscopic, and general surgery devices and components, such as harmonic scalpels, shaver blades, burr shavers, radio frequency probes, biopsy probes, trocars, electrocautery components, wound dressings, GERD treatment components, and phacoemulsification needles. Further, it provides orthopedic products that include instruments used in hip, knee, and spine surgeries, as well as reamers and chisels. Additionally, the company offers customized battery power and power management systems, and battery solutions for the energy, military, and environmental markets. Furthermore, the company provides medical technologies. It serves multi-national original equipment manufacturers and their affiliated subsidiaries in the cardiac rhythm management, neuromodulation, orthopedics, vascular, and advanced surgical and portable medical markets. Integer Holdings Corporation was founded in 1970 and is headquartered in Plano, Texas.

Corporate Governance

Integer Holdings Corporations ISS Governance QualityScore, Stand 1. Juni 2024, lautet 2. Die grundlegenden Scores sind Audit: 4, Vorstand: 2, Shareholderrechte: 2, Kompensation: 3.

Corporate-Governance-Bewertungen von Institutional Shareholder Services (ISS). Die Werte geben den Zehntelwert im Verhältnis zum Index oder zur Region an. Ein Zehntelwert von 1 zeigt geringeres Governance-Risiko, 10 höheres Governance-Risiko.